Benefit of daflon 500 mg in chronic venous disease-related edema

Phlebolymphology

Volumn 13, Issue 1, 2006, Pages 17-21

  Pitsch, Françoise ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Chronic venous disease; Diagnosis; Edema; Lymphatic disorders; Micronized purified flavonoid fraction

Indexed keywords

DAFLON;

CAPILLARY PERMEABILITY; CHRONIC DISEASE; CHRONIC VEIN DISEASE; CHRONIC VEIN INSUFFICIENCY; DEVICE; EDEMA; HUMAN; LYMPH FLOW; LYMPHATIC SYSTEM DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK BENEFIT ANALYSIS; VEIN DISEASE; VOLUMETRY;

EID: 29344466184     PISSN: 12860107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Terry M, Scan P, O'Brien M, et al. Lower-extremity edema: evaluation and diagnosis. Wounds. 1998;10:118-124.
2. Vayssairat M. The causes of edema in chronic venous insufficiency. Phlebolymphology. 2003;41:168-176.
3. Garde C. First consensus meeting on venoactive agents and review of their clinical benefits. Phlebolymphology. 2005;49:384-396.
4. Allegra C, Antignani PL, Bergan JJ, et al. The "C" of CEAP: Suggested definitions and refinements: An International Union of Phlebology conference of experts. J Vasc Surg. 2003;37:129-131.
5. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: Consensus statement. J Vasc Surg. 2004;40:1248-1252.
6. Rutherford RB, Padberg FT Jr, Comerota AJ, et al. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000;31:1307-1312.
7. Blanchemaison P. Physiopathologie et classification des oedèmes vasculaires [in French]. Angeiologie. 2000;52:47-50.
8. Vayssairat M, Maurel A, Gouny P, et al. La volumétrie à eau: une méthode précise de quantification en phlébologie. J Mal Vasc. 1994;19:108-110.
9. Tierney S, Aslam M, Rennie K, et al. Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg. 1996;12:412-417.
10. Pani SP, Vanamail P, Yuvaraj J. Limb circumference measurements for recording edema volume in patients with filarial lymphedema. Lymphology. 1995;28:57-63.
11. Berard A, Kurz X, Zuccarelli F, et al. Validity of the Leg-O-Meter®, an instrument to measure leg circumference. Angiology. 2002;53:21-28.
12. Chassignolle JF, Amiel M, Lanfranchi G, et al. Activité thérapeutique de Daflon® 500 mg dans l'insuffisance veineuse fonctionnelle. JIM. 1987;99(suppl):32-35.
13. Gilly R, Pillion G, Frileux C. Evaluation of a new vasoactive micronized flavonoid fraction (S 5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: a double-blind, placebo-controlled study. Phlebology. 1994;9:67-70.
14. Jantet G, and the RELIEF Study Group. Chronic venous insufficiency - worldwide results of the RELIEF study. Angiology. 2002;53:245-256.
15. Blume J, Langenbahn H, De Champvallins M. Quantification of oedema using the volometer technique: therapeutic application of Daflon® 500 mg in chronic venous insufficiency. Phlebology. 1992;(suppl 2):37-40.
16. Cospite M, Dominici A. Advantage of micronisation of Daflon® 500 mg compared with a simple diosmin in the treatment of venous insufficiency. Double blind study. Phlébologie. 1998;51:243-247.
17. Italian College of Phlebology. Guidelines for the diagnosis and treatment of chronic venous insufficiency. Int Angiol. 2001;20(2 Suppl 2):1-37.
18. Coleridge Smith PD. The drug treatment of chronic venous insufficiency and venous ulceration. In: Gloviczki P, Yao JST, editors. Handbook of Venous Disorders: Guidelines of the American Venous Forum. 2nd ed. London: Arnold; 2001:309-321.
19. Lyseng-Williamson KA, Perry CM. Micronised purified flavonoid fraction. A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs. 2003;63:71-100.